Skyve Unveils Integrated Platform for AI Surgical Planning, Collaboration, and Simulation

원본보기 아이콘

Skyve Co., Ltd., a company specializing in orthopedic digital healthcare and medical devices, has completed and unveiled a patient-specific surgical platform based on AI technology.

The newly completed platform utilizes artificial intelligence to precisely analyze CT and MRI images, reconstructs the patient's anatomical structure in 3D, and provides an integrated surgical system that encompasses surgical planning, custom instrument manufacturing, and simulation in collaboration with medical professionals.

Existing patient-specific solutions have faced technical limitations, as most relied solely on CT images and could not reflect cartilage structures. MRI-based imaging, on the other hand, has mostly required manual work, resulting in limited clinical utility.

To address these issues, Skyve independently developed 'ZIFT,' a deep learning-based image analysis software that automatically converts both CT and MRI data into 3D models. This advancement enables precise anatomical reproduction, including not only bones and joints but also cartilage.

Additionally, the company operates 'Onknee-U,' an AI-based software that simulates surgical paths and cutting ranges, and 'KNEESIGN,' a collaborative platform that allows medical professionals to review and modify surgical plans in real time via the web. KNEESIGN is being applied not only to knee joint replacement surgeries but also to HTO (high tibial osteotomy) procedures for correcting bowlegs, thereby expanding its surgical applications.

In the final stage of the platform, a patient-specific surgical instrument called 'KNEEVIGATE' is produced using 3D printing based on the finalized surgical data. If needed, the platform can be expanded to include 'Sagarvision,' an AR (augmented reality)-based simulation tool.

Through this platform, Skyve has digitalized every step of surgical preparation, from image analysis to surgical planning and instrument manufacturing. As a result, the company has succeeded in reducing the average production time for surgical instruments from the conventional 1 to 2 weeks to just 2 days. In particular, the MRI-based cartilage visualization technology and real-time collaborative structure represent clear technological distinctions from existing overseas solutions.

Kang Kyungtak, CEO of Skyve, stated, "The key lies in integrating previously separate processes?image analysis, surgical planning, instrument manufacturing, and execution?into a single platform," adding, "Collaboration-based surgical planning through KNEESIGN can greatly enhance the precision and speed of patient-specific surgeries."

He also emphasized, "KNEEVIGATE is not just a simple surgical instrument, but a convergence of AI, MRI, and collaboration-based platform technologies," and added, "We aim to establish it as a new standard in orthopedic surgery through registration as a new medical technology."

Skyve is currently working toward registering KNEEVIGATE as a new medical technology and is accelerating efforts to secure clinical reliability through collaboration with hospitals and medical professionals. In particular, the MRI-based cartilage surgical planning technology stands out as a unique strength that is difficult for overseas competitors to replicate, attracting attention in the global market.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.